CVS Health Corporation (CVS)

CVS Health (CVS) reached $76.87 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.

Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new Trump...

CVS Health said on Wednesday its health insurance unit will offer medicare advantage prescription drug plans in 43 states and Washington D.C. for 2026.

One of the best ways for any investor to lock in additional portfolio upside is to start exploring areas where few others are willing to venture, especially when those are the least popular ones in th...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CVS Health remains a solid, undervalued business, despite recent underperformance, versus the S&P 500 and ongoing margin pressures. Q2/25 results showed strong revenue growth but declining operating i...

The latest trading day saw CVS Health (CVS) settling at $76.47, representing a +1.78% change from its previous close.

CVS strengthens Caremark's PBM edge with formulary shifts, new partnerships and cost-saving wins for clients.

Omnicare, a CVS Health subsidiary that provides pharmacy services to skilled nursing facilities, independent and assisted living communities and other segments of the long-term care market, filed for ...